From January 27, 1992 to December 12, 1994, 100 consecutive patients (
86 men and 14 women) with a mean age of 62.5 years underwent lung rese
ction for a non-small cell lung cancer. Squamous cell carcinoma was pr
edominantly found (52%), followed by adenocarcinoma (23%) and large ce
ll carcinoma (18%). Postoperative staging was Stage 0, 1 patient; Stag
e I, 57; Stage II, 17; Stage IIIa, 20 and Stage IIIb, 5. Thirty-day mo
rtality was 4% (4 patients) with 10.7% for pneumonectomy and 0% for lo
bectomy or lesser resection. For the whole group 1-, 2- and 3-year sur
vival rates were 83%, 68% and 65% respectively. Survival rates for NO,
N1 and N2 after 3 years were 70%, 59% and 54% respectively. In the un
ivariate analysis, a trend to statistical significance was noted betwe
en NO and N1 (p=0.08). There was no difference in short-term survival
between NO and N2 which represents a highly selected group of patients
with N2 disease. In the multivariate analysis the only two independen
t variables with impact on survival were number of pack-years and diam
eter of the tumour (p <0.05). Ninety-two quality of life questionnaire
s (EORTC QLQ-C30) were sent to home physicians. We collected 31 questi
onnaires (34%) after 2.5 months. A clear relationship was not seen bet
ween complaints of pain or dyspnea and extent of resection or lung fun
ction postoperatively. Instead, the global quality of life seemed to b
e influenced by the extent of resection to the advantage of a lobectom
y and disadvantage of a pneumonectomy. Difficulties related to quality
of life analysis are discussed and future directions are given.